The purpose of this study was to investigate PLAGL2 expression associated with pathological features and prognosis and predicted lymph node metastases in the bladder urothelial carcinoma (BUC) tissue. The gene discussed is PLAGL2; the disease is bladder transitional cell carcinoma.